Stocksigma LogoStocksigma Logo

Mono Pharmacare Fined by NSE for Regulatory Non-Compliance

NSE levied penalties totaling ₹2,02,960 on Mono Pharmacare Limited for compliance delays, including ₹1,71,100 under Regulation 33 of SEBI LODR Regulations

Mono Pharmacare Fined by NSE for Regulatory Non-Compliance

Mono Pharmacare Ltd · Others (Uncategorized) · 09 Sept 2026, 11:13 pm

Mono Pharmacare Fined by NSE for Regulatory Non-Compliance NSE levied penalties totaling ₹2,02,960 on Mono Pharmacare Limited for compliance delays, including ₹1,71,100 under Regulation 33 of SEBI LODR Regulations, 2015, and ₹31,860 under Regulation 76 of SEBI (Depositories and Participants) Regulations, 2018, following notices issued on 30th Jun'26 and 5th Jun'26, respectively. The company confirmed it has taken corrective actions to achieve full compliance, while the Board directed management to strengthen internal compliance mechanisms to avoid future regulatory lapses.

Original exchange filing (PDF)

More announcements from Mono Pharmacare Ltd

All Mono Pharmacare Ltd announcements